Wearable cardioverter‐defibrillator: friend or foe in suspected myocarditis?

Wearable cardioverter‐defibrillator: friend or foe in suspected myocarditis?

Abstract Aim Wearable cardioverter defibrillator (WCD, LifeVest, and Zoll) therapy has become a useful tool to bridge a temporarily increased risk for sudden cardiac death. However, despite extensive use, there is a lack of evidence whether patients with myocarditis and impaired LVEF may benefit fro...

Full description

Bibliographic Details
Main Authors: Florian Blaschke, Philipp Lacour, Phi Long Dang, Abdul Shokor Parwani, Felix Hohendanner, Thula Walter, Karin Klingel, Uwe Kühl, Frank R. Heinzel, Mohammad Sherif, Leif‐Hendrik Boldt, Burkert Pieske, Carsten Tschöpe
Format: Article
Language:English
Published: Wiley 2021-08-01
Series:ESC Heart Failure
Subjects:
Myocarditis
Arrhythmias
Wearable cardioverter defibrillator
Endomyocardial biopsy
Online Access:https://doi.org/10.1002/ehf2.13340

Internet

https://doi.org/10.1002/ehf2.13340

Similar Items